154 related articles for article (PubMed ID: 34797618)
1. Evolution of SARS-CoV-2 seroprevalence and clusters in school children from June 2020 to April 2021: prospective cohort study Ciao Corona.
Ulyte A; Radtke T; Abela IA; Haile SR; Ammann P; Berger C; Trkola A; Fehr J; Puhan MA; Kriemler S
Swiss Med Wkly; 2021 Oct; 151():w30092. PubMed ID: 34797618
[TBL] [Abstract][Full Text] [Related]
2. Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools.
Ulyte A; Radtke T; Abela IA; Haile SR; Berger C; Huber M; Schanz M; Schwarzmueller M; Trkola A; Fehr J; Puhan MA; Kriemler S
BMJ; 2021 Mar; 372():n616. PubMed ID: 33731327
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 seroprevalence in children, parents and school personnel from June 2020 to April 2021: cohort study of 55 schools in Switzerland.
Ulyte A; Haile SR; Blankenberger J; Radtke T; Puhan MA; Kriemler S
Swiss Med Wkly; 2022 Jun; 152():w30193. PubMed ID: 35752960
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous evolution of SARS-CoV-2 seroprevalence in school-age children: Results from the school-based cohort study Ciao Corona in November-December 2021 in the canton of Zurich.
Haile SR; Raineri A; Rueegg S; Radtke T; Ulyte A; Puhan MA; Kriemler S
Swiss Med Wkly; 2023 Jan; 153():40035. PubMed ID: 36787493
[TBL] [Abstract][Full Text] [Related]
5. Variation in SARS-CoV-2 seroprevalence across districts, schools and classes: baseline measurements from a cohort of primary and secondary school children in Switzerland.
Ulyte A; Radtke T; Abela IA; Haile SR; Blankenberger J; Jung R; Capelli C; Berger C; Frei A; Huber M; Schanz M; Schwarzmueller M; Trkola A; Fehr J; Puhan MA; Kriemler S
BMJ Open; 2021 Jul; 11(7):e047483. PubMed ID: 34312201
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence and immunity of SARS-CoV-2 infection in children and adolescents in schools in Switzerland: design for a longitudinal, school-based prospective cohort study.
Ulyte A; Radtke T; Abela IA; Haile SR; Braun J; Jung R; Berger C; Trkola A; Fehr J; Puhan MA; Kriemler S
Int J Public Health; 2020 Dec; 65(9):1549-1557. PubMed ID: 33063141
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.
Zinszer K; McKinnon B; Bourque N; Pierce L; Saucier A; Otis A; Cheriet I; Papenburg J; Hamelin MÈ; Charland K; Carbonneau J; Zahreddine M; Savard A; Fortin G; Apostolatos A; Haley N; Ratté N; Laurin I; Nguyen CT; Conrod P; Boivin G; De Serres G; Quach C
JAMA Netw Open; 2021 Nov; 4(11):e2135975. PubMed ID: 34812845
[TBL] [Abstract][Full Text] [Related]
8. Perceptions towards mask use in school children during the SARS-CoV-2 pandemic: descriptive results from the longitudinal Ciao Corona cohort study.
Ammann P; Ulyte A; Haile SR; Puhan MA; Kriemler S; Radtke T
Swiss Med Wkly; 2022 Apr; 152():w30165. PubMed ID: 35748765
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of anti-SARS-CoV-2 antibodies among children and their parents in Greece.
Dimopoulou D; Kyritsi M; Dadouli K; Vergadi E; Tsiligianni E; Papadimitriou E; Mavridi A; Giannakopoulos S; Tsiourvopoulou G; Palyvou M; Angeli E; Brikos N; Eleftheriou I; Spoulou V; Michos A; Gkentzi D; Siomou E; Papaevangelou V; Grivea I; Syrogiannopoulos G; Galanakis E; Hadjichristodoulou C; Tsolia M
Eur J Pediatr; 2023 Jan; 182(1):439-449. PubMed ID: 36383284
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of Acute SARS-CoV-2 Infections in School Children and Point-Prevalence During a Time of High Community Transmission in Switzerland.
Kriemler S; Ulyte A; Ammann P; Peralta GP; Berger C; Puhan MA; Radtke T
Front Pediatr; 2021; 9():645577. PubMed ID: 33796490
[No Abstract] [Full Text] [Related]
11. Prediction of Past SARS-CoV-2 Infections: A Prospective Cohort Study Among Swiss Schoolchildren.
Blankenberger J; Haile SR; Puhan MA; Berger C; Radtke T; Kriemler S; Ulyte A
Front Pediatr; 2021; 9():710785. PubMed ID: 34485200
[No Abstract] [Full Text] [Related]
12. Seroprevalence of anti-SARS-CoV-2 antibodies among school and daycare children and personnel: protocol for a cohort study in Montreal, Canada.
Zinszer K; McKinnon B; Bourque N; Zahreddine M; Charland K; Papenburg J; Fortin G; Hamelin MÈ; Saucier A; Apostolatos A; Pierce L; Savard-Lamothe A; Carbonneau J; Conrod P; Haley N; Laurin I; Boivin G; De Serres G; Quach C
BMJ Open; 2021 Jul; 11(7):e053245. PubMed ID: 34244288
[TBL] [Abstract][Full Text] [Related]
13. Transmission of SARS-CoV-2 by children to contacts in schools and households: a prospective cohort and environmental sampling study in London.
Cordery R; Reeves L; Zhou J; Rowan A; Watber P; Rosadas C; Crone M; Storch M; Freemont P; Mosscrop L; Cowley A; Zelent G; Bisset K; Le Blond H; Regmi S; Buckingham C; Junaideen R; Abdulla N; Eliahoo J; Mindlin M; Lamagni T; Barclay W; Taylor GP; Sriskandan S
Lancet Microbe; 2022 Nov; 3(11):e814-e823. PubMed ID: 36029775
[TBL] [Abstract][Full Text] [Related]
14. Study protocol for monitoring SARS-CoV-2 infection and its determinants in Catalonia (Spain): an observational and participatory research approach in a Sentinel Network of Schools.
Bordas A; Soriano-Arandes A; Subirana M; Malagrida R; Reyes-Urueña JM; Folch C; Soler-Palacin P; Gascón M; Sunyer J; Anton A; Blanco I; Fernández-Morales J; Colom-Cadena A; Sentís A; Pumarola T; Basora J; Casabona J;
BMJ Open; 2022 Jan; 12(1):e055649. PubMed ID: 35078847
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 seroprevalence in students and teachers: a longitudinal study from May to October 2020 in German secondary schools.
Kirsten C; Unrath M; Lück C; Dalpke AH; Berner R; Armann J
BMJ Open; 2021 Jun; 11(6):e049876. PubMed ID: 34112645
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study.
Richard A; Wisniak A; Perez-Saez J; Garrison-Desany H; Petrovic D; Piumatti G; Baysson H; Picazio A; Pennacchio F; De Ridder D; Chappuis F; Vuilleumier N; Low N; Hurst S; Eckerle I; Flahault A; Kaiser L; Azman AS; Guessous I; Stringhini S
Scand J Public Health; 2022 Feb; 50(1):124-135. PubMed ID: 34664529
[No Abstract] [Full Text] [Related]
17. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of SARS-CoV-2 in German secondary schools from October 2020 to July 2021: a longitudinal study.
Kirsten C; Kahre E; Blankenburg J; Schumm L; Haag L; Galow L; Unrath M; Czyborra P; Schneider J; Lück C; Dalpke AH; Berner R; Armann J
Infection; 2022 Dec; 50(6):1483-1490. PubMed ID: 35460495
[TBL] [Abstract][Full Text] [Related]
19. Assessment of population infection with SARS-CoV-2 in Ontario, Canada, March to June 2020.
Bolotin S; Tran V; Deeks SL; Peci A; Brown KA; Buchan SA; Ogbulafor K; Ramoutar T; Nguyen M; Thakkar R; DelaCruz R; Mustfa R; Maregmen J; Woods O; Krasna T; Cronin K; Osman S; Joh E; Allen VG
Euro Surveill; 2021 Dec; 26(50):. PubMed ID: 34915969
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 infection prevention and control measures in Belgian schools between December 2020 and June 2021 and their association with seroprevalence: a cross-sectional analysis of a prospective cohort study.
Callies M; Kabouche I; Desombere I; Merckx J; Roelants M; Vermeulen M; Duysburgh E
BMC Public Health; 2023 May; 23(1):898. PubMed ID: 37194008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
